Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 May 25;35(1):25–33. doi: 10.1002/hon.2238

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. Hematological Oncology published by John Wiley & Sons Ltd

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Methylation and expression of RUNDC3B in patient samples. The results shown here are based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. (A) Expression of RUNDC3B in 41 chronic lymphocytic leukaemia (CLL) patients and 11 normal controls. The red bars and the left axis represent normalized counts. The blue squares and the right axis represent the percentile rank within the sample. (B) Methylation and expression in acute myeloid leukaemia (AML) patients. Methylation shown in grey box (left panel) for 11 cytosines (vertical bars) present in the RUNDC3B CGI. Proportional expression is shown in the right panel. (C) Methylation and expression in diffuse large B‐cell lymphoma (DLBCL) patients. Proportional methylation shown in grey box (left panel) for 11 cytosines (vertical bars) present in the RUNDC3B CGI. Proportional expression is shown in the right panel. Blue to red scale represents lowest to highest methylation and expression values